1. Home
  2. EXEL vs LKQ Comparison

EXEL vs LKQ Comparison

Compare EXEL & LKQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • LKQ
  • Stock Information
  • Founded
  • EXEL 1994
  • LKQ 1998
  • Country
  • EXEL United States
  • LKQ United States
  • Employees
  • EXEL N/A
  • LKQ N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • LKQ Motor Vehicles
  • Sector
  • EXEL Health Care
  • LKQ Consumer Discretionary
  • Exchange
  • EXEL Nasdaq
  • LKQ Nasdaq
  • Market Cap
  • EXEL 12.0B
  • LKQ 9.8B
  • IPO Year
  • EXEL 2000
  • LKQ 2003
  • Fundamental
  • Price
  • EXEL $45.40
  • LKQ $38.61
  • Analyst Decision
  • EXEL Buy
  • LKQ Strong Buy
  • Analyst Count
  • EXEL 18
  • LKQ 5
  • Target Price
  • EXEL $44.29
  • LKQ $52.60
  • AVG Volume (30 Days)
  • EXEL 2.7M
  • LKQ 1.8M
  • Earning Date
  • EXEL 07-28-2025
  • LKQ 07-24-2025
  • Dividend Yield
  • EXEL N/A
  • LKQ 3.11%
  • EPS Growth
  • EXEL 237.58
  • LKQ N/A
  • EPS
  • EXEL 2.20
  • LKQ 2.68
  • Revenue
  • EXEL $2,298,922,000.00
  • LKQ $14,115,000,000.00
  • Revenue This Year
  • EXEL $9.93
  • LKQ $0.13
  • Revenue Next Year
  • EXEL $13.17
  • LKQ $3.12
  • P/E Ratio
  • EXEL $20.60
  • LKQ $14.42
  • Revenue Growth
  • EXEL 24.49
  • LKQ N/A
  • 52 Week Low
  • EXEL $22.20
  • LKQ $35.56
  • 52 Week High
  • EXEL $49.62
  • LKQ $45.70
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 57.52
  • LKQ 53.74
  • Support Level
  • EXEL $43.86
  • LKQ $36.95
  • Resistance Level
  • EXEL $45.52
  • LKQ $37.94
  • Average True Range (ATR)
  • EXEL 1.44
  • LKQ 0.79
  • MACD
  • EXEL -0.07
  • LKQ 0.09
  • Stochastic Oscillator
  • EXEL 39.60
  • LKQ 58.87

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About LKQ LKQ Corporation

Since forming in 1998 to consolidate the auto salvage business in the United States, LKQ has developed into a leading distributor of aftermarket and recycled auto parts with around 1,500 facilities across North America and Europe. The company primarily sells into the professional channel and offers an assortment of collision and mechanical parts to both body shops and mechanical repair shops. It also continues to operate more than 70 LKQ pick-your-part junkyards. Separate from the self-service business, LKQ usually purchases around 250,000 salvage vehicles annually that are used to extract vehicle parts for resale.

Share on Social Networks: